undamentalytics Newsletter

HCA Healthcare income statement

In fiscal 2025, HCA Healthcare reported revenue of $75.60bn, up 7.1% on the year before and net income of $6.78bn, or $28.33 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

HCA Healthcare: income statement, annual
Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue41.543.646.751.351.558.860.265.070.675.678.7
General and administrative0.30.30.30.40.40.30.30.40.40.50.6
Interest expense1.71.71.81.81.61.61.71.92.12.22.4
Income before tax4.84.45.35.25.49.88.67.78.59.89.8
Income tax1.41.60.91.11.02.11.71.61.92.12.0
Net income2.92.23.83.53.87.05.65.25.86.86.8
Diluted EPS$7.30$5.95$10.66$10.07$10.93$21.16$19.15$18.97$22.00$28.33$30.21
Diluted shares (average)396m372m355m348m344m329m295m276m262m239m224m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HCA vs UHSENSG vs HCAHCA vs PACS

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from HCA Healthcare's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to HCA Healthcare.